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Introduction
The veterinarians and other health professional
commonly encounter inter-individual variations in
response to drug administration. Some patients
respondwelltoaparticulartherapy,whileothersfailto
demonstrate idiosyncrasy. Often, small animal
clinicians are informed by the dog owners or breeders
that their dogs are sensitive to a particular type of
medication. This variation in drug response among
individuals is due to the varied genetic make-up which
explains the adverse drug reactions and offers a major
step towards safe pharmacotherapy. Therefore, phar-
macogenetics has been used to explain idiosyncratic
drug reactions in veterinary patients. The genotype-
specificapproachestotherapyinchildhood(GATC),a
national Adverse Drug Reaction (ADR) network, has
been established in Canada in 2005 to report specific
ADRs in children and identify the predictive genomic
biomarkers of drug risk and thus, to provide a
frameworkofADRsurveillance[1].
Adversedrugreactions(ADRs)areassociated
with serious harmful effects and may lead to death in
both human and animal patients. ADRs are ranked as
the fifth major cause of mortality in human population
of the western world [1]. Around 2.9–5.6 % of all
humanpatientsadmittedtohospitalssufferfromADRs
andasmanyas35%ofthemexperienceanADRduring
their stay in hospital. The overall incidence of serious
ADRs is 6.7 % and of fatal ADRs is 0.32 % in
hospitalized patients [2]. A recent study in Turkey
revealedthatmaximumcasesonADRinanimalswere
reported from vitamin-mineral-amino acid preparations
(39%), followed by antibacterials and anthelmentics
(26%).Themostobservedadversedrugreactionswere
anaphylaxis and the local reactions at the injected site
[3].ThedocumentedincidenceofADRinpetsislower
thanthatofhuman,probablyduetofewerdrugsprescribed
per animal patients human patients, and poor
investigations on ADR in animal patients following
drug administration. ADR, in many occasions, is
erroneously attributed to disease progression or the
onsetofanotherdiseaseprocessinsteadofbeingeasily
recognized [4]. The use of drugs, biological, vaccines,
and dietary supplements is aimed at beneficial thera-
peuticoutcomes,providedtheyarebeingusedinaccurate
dose and diseases and the outcome is thoroughly
monitored. However, their use is associated with
inherentrisksbothinhumanandveterinarypractice.
ADRs are the frequently seen problems and
resultsindeleterioushealthconsequencesandremaina
serious challenge in terms of associated morbidity and
mortality [5]. Several plant-based medicinal products
vis-a-vis
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Abstract
Anadversedrugreaction(ADR)isaseriousconcernforpracticingveterinariansandotherhealthprofessionals,andrefersto
anunintended,undesiredandunexpectedresponsetoadrugthatnegativelyaffectsthepatient'shealth.Itmaybeiatrogenicor
genetically induced, and may result in death of the affected animal. TheADRs are often complicated and unexpected due to
myriad clinical symptoms and multiple mechanisms of drug-host interaction. Toxicity due to commonly used drugs is not
uncommonwhentheyareusedinjudiciouslyorforaprolongedperiod.Licosamides,exclusivelyprescribedagainstanaerobic
pyoderma, often ends with diarrhoea and vomiting in canines. Treatment with Penicillin and -lactam antibiotics induces
onset of pemphigious vulgare, drug allergy or hypersensitivity. Chloroamphenicol and aminoglycosides causes Gray's baby
syndrome and ototoxicity in puppies, respectively. Aminoglycosides are very often associated with nephrotoxicity,
ototoxicity and neuromuscular blockage. Injudicious use of fluroquinones induces the onset of arthropathy in pups at the
weight bearing joints.The most effective therapeutic measure in managingADR is to treat the causative mediators, followed
by supportive and symptomatic treatment. So, in this prospective review, we attempt to bring forth the commonly occurring
adverse drug reactions, their classification, underlying mechanism, epidemiology, treatment and management as gleaned
fromtheliteratureavailabletilldateandthedifferentclinicalcasesobservedbytheauthors.
adversedrugreaction, druginteraction,hypersensitivity,toxicity.
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have been evaluated for ameliorating the toxic effects,
even after ADR reported following administration of
anticancerdrug,cisplastin[6].
In this review we have detailed down the ADR
associated with common antibacterials, mechanisms
governing them as well as the steps involved in
management and treatment. This document would
serve as an overview for the veterinary clinicians and
hence, prevent future injuries for companion animal
practice.
There is no universally accepted definition for an
ADR Most definitions are more or less similar to that
explainedbytheWorldHealthOrganization(WHO)or
the United States Food and Drug Administration
(USFDA).AspertheWHOdefinition,anadversedrug
event is any response to a drug that is noxious and
unintendedindosesnormallyusedinpeopleoranimals
for diagnosis, prevention, and treatment. On the other
hand, the USFDA describes serious adverse drug
events as events that result in patient's death, life-
threatening outcomes, hospitalization, disability,
congenital anomaly, and outcomes requiring
healthcare interventions [1, 3]. Some ADRs may be
predictable, based upon a drug's pharmacodynamic
and pharmacokinetic properties or may be
idiosyncratic due to underling genetic factors. Hence,
an identification of predisposing genotypes may
improve patient management through the prospective
selectionofappropriateremedy[4].
ADRs are often classified as type-A occurring
frequentlyandtypicallydoserelatedandtype-B,which
is often, termed as idiosyncratic reactions. Type-A
reactions represent an extension of the drug's
therapeutic effect occurring frequently, such as
bleedingepisodeswithwarfarinization[7].Incontrast,
type-B reactions are unpredictable and occur only in
susceptible individuals. The drug reactions can again
be classified into immunologic and non-immunologic
etiologies. Nearly 70-80 % of ADRs are caused by
predictable, non-immunologic factors. The remaining
20-25 % ofADRs is unpredictable which may or may
not be immune-mediated. Only 5 to 10% of these
reactions constitute true drug hypersensitivity and are
mostly IgE-mediated [8]. Toxic effects such as
anticholinergic effects of tricyclic antidepressants,
digitoxin toxicity and serotonin syndrome are dose
related; whereas immunological reaction like
ampicillin rash, penicillin hypersensitivity, malignant
hyperthermia, and idiosyncratic reactions are not
related to dose. Moreover, hypothalamic-pituitary-
adrenal axis suppression following corticosteroids
therapyisattributedtodose-andtimerelatedreactions.
Sometimes, myocardial ischemia
Immunological drug reactions
include a serum
sicknessfromanti-thymocyteglobulin,contactdermatitis
from topical antihistamine, hemolytic anaemia from
penicillin,morbilliformrashfromsulphonamides,anti-
convulsant hypersensitivity syndrome, toxic epidermal
necrolysis, drug-induced lupus-like syndrome [9].
Similarly, dry mouth from antihistamines, hepato-
toxicityfrommethotrexate,thrushwhiletakingantibiotic,
seizurefromtheophy-lline,whiletakingerythromycin,
and seizure from excessive lidocaine (xylocaine) are
the examples of predictable non-immunologic drug
reactions.Unpredictablenon-immunologicdrugreactions
include pseudoallergic, idiosyncratic and intolerance
[9].
Pseudoallergic reactions are mostly caused by
direct activation of the mast cells and their degranu-
lation by drugs such as opiates, vancomycin and
radiocontrast media. The clinical signs are often same
as that of type-I hypersensitivity, except that they do
not involve drug specific IgE. Idiosyncratic reactions
are often unpredicted and are qualitatively aberrant
reactions with much less prevalence. Drug-induced
hemolysis with deficiency of glucose-6-phosphate
dehydrogenase(G6PD)isagoodexampleofidiosyncratic
reaction. However, drug intolerance explains a lower
thresholdtothenormalpharmacologicactionofadrug.
Presence of a foreign substance or drug or
xenobiotic activate T-cells, which in turn express skin
homing receptors, necessary for presentation of
allergen and thus ultimately leads to cellular apoptosis
andinflammation[9].
Epidemiological data support the existence of
specific factors that increase the risk of ADR. Female
gender, infection with human immunodeficiency virus
(HIV),andherpesvirusinfectionhavebeenreportedto
increasetherisk.Asthma,systemiclupuserythematosus
and use of blockers increases the risk for drug
hypersensitivityreactions[10].Atopicpatientshavean
increased risk for serious allergic reactions [11].ADR
have been largely confined to children. Recent studies
have reported that ADR is three times higher among
pediatric patients as compared to adults [12], develop-
mentally associated with changes in drug disposition,
metabolism,clearancepharmacokinetics,andpharma-
codynamics [12, 13]. Reviewing of human literature
willgivealeadforexploitationandfurtherapplication
of this knowledge in veterinary medicine. Suboptimal
or inappropriate prescribing is highly prevalent in
geriatric patients, and is becoming a global healthcare
concern in the present worldwide elderly population
demographics[14].
Veterinary dermatological patients may be
particularlyatriskduetonecessaryandfrequentuseof
multiple drugs to achieve the desired therapeutic
outcome. Treatment often involves drugs that have
been implicated in adverse reactions and toxicity in
other patients including antimicrobials, external and
internalanti-parasiticdrugs,antifungal,anti-inflammatory
drugs, general anaesthetics, tranquilizers, oncolytic
Adverse drug reaction
Classification
.
occurs in patients
due to immediate withdrawal of -blockers, if not
withdrawn slowly.
naphylaxis from -lactam antibiotic,
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agents, vitamins, hormones, etc. There are thousands
of recognized drug interactions and some may only be
reported in human medicine and are not applicable to
veterinary practice. On the other hand, there may be a
significantnumberofinteractionsthatoccuronlyinthe
species we are treating in pet and companion animals.
Someofthemostcommonlyprescribedanti-microbial
agents and reported to be have toxic effects in dogs are
described.
The sulphonamides such as sulfame-
thoxazole, sulfadiazine, sulfadimethoxine have been
reported to cause numerous dose-dependant reactions
in dogs including haematuria, non-regenerative anemia,
interfered thyroxine synthesis, erythema multiforme,
erythema nodosum, photosensitivity, urticarial rashes
andmanyotherskindiseases[15].Themechanismand
time course of these reactions vary considerably from
species to species. Anaphylaxis may not accompany
the initial cutaneous drug reactions, but re-exposure
canexacerbatethislife-threateningreaction.Theseare
immediate type immune-mediated reactions due to
presenceofIgEantibodiesagainstthesulfonamide[15,
16]. Binding specificity studies suggest that the 5-
methyl-3-isoxazolyl group on sulfonamides is an
active component in antibody recognition [16]. Such
reactions occurring across a spectrum of sulfonamides
in a given dog is suggested from cross-reactivity
withinavarietyofsulfonamides.Fevertogetherwitha
morbilliform or maculopapular, non-urticarial skin
rashes are generally manifested by 7-14 days post-
initiation of therapy with sulfonamide. Bio-activation
ofsulphonamidemayresultfromformationofmetabolite-
protein conjugates as inferred from
studies demonstrating the ability of reactive metabolites
of sulfonamides to bind covalently to proteins [17].
This implies that the slow acetylator phenotype patients
are at a greater risk of toxicity as they bioactivate a
largerfractionoftheadministereddose cytochrome
P   .
Penicillinanditsderivativesarethecommon
causeofADRwhichvaryfromamorbilliformeruption
toanaphylaxis[15,18].Ampicillinandamoxycillinare
most commonly implicated in morbilliform drug
reactions. The high cutaneous reaction rate may be
attributed to the diacyl side chain of these compounds
that gives rise to the formation of linear polymers.
Acutegeneralizedexanthematouspustulosisiscommonly
caused by -lactam and macrolide antibiotics [18].
Histological section demonstrates an intraepidermal
spongiformpustulewitheosinophils.
The incidence of true cross-reactivity between
penicillinsandcephalosporinsispoorlyrecorded.Still,
the patient's owners are often advised against fatal
anaphylaxis while administering cephalosporin to pets
with a history of penicillin allergy [19, 20]. However,
since 1980 the degree of cross-reactivity between
penicillin and current-generation cephalosporins has
been found to be less than 5 % [20]. In such cases
, penicillin skin testing is advised [21].
Carbapenem is also restricted in penicillin allergy due
to the evidence of cross reactivity between other
antibiotics and penicillin [19, 22]. In such
situations,aztreonam(Azactam)issafelyadministered
becauseofextremelyrarecross-reactivity.
The penicillin and cephalosporin
are -lactam antibiotics structurally characterised by a
five-membered thiazolidine ring and a six-membered
dihydrothiazine ring respectively. Risk of adverse
cutaneousreactiontocephalosporinsinapatientwitha
historyofpenicillinallergyiscontroversial,butbecomes
visible to be quite low. Both cephalosporins and the
penicillinshavebeenimplicatedininducingapemphigus-
like syndrome [18, 19, 22].The same syndrome is also
induced by thiol drugs including captopril, D-penicill-
amine,andgoldsodiumthiomalatewhichischaracterized
by flaccid bullae clinically indistinguishable from
pemphigus vulgaris that develop within the first few
weeks of drug therapy. Direct immunofluorescence
demonstratesIgGantibodiestargetingthekeratinocyte
desmosomal components desmoglein I or III [19, 20].
Cephalosporin also induces the onset of gastrointestinal
disturbances,hemolysisandglycosuriaindogs.
Renal damage and ototoxicity
have been linked to repeated aminoglycoside adminis-
tration or its overuse. The renal damage ranges from
mild, subclinical changes to more severe nephrotoxicity
and acute renal failure [23]. The animal's ability to
improvedependsonthenatureofmedicationexposure
and the quantity of healthy renal tissue remaining to
compensate [24]. Neomycin is considered as the most
nephrotoxic while aminoglycoside, dihydrostrepto-
mycin and streptomycin are least nephrotoxic, and the
other common aminoglycosides are considered some-
where intermediate between those three drugs in their
toxicity [25]. Aminoglycosides cause nephrotoxicity
by accumulating in the proximal tubular cells and
interferewithcellularmetabolismandtransportprocesses
by establishing lysosomal phospholipid complexes
[25, 26]. These tubular changes can progress to
proximal tubular necrosis with increasing exposure to
the drug [26, 27]. The toxic renal changes caused by
gentamicin and other aminoglycosides lessen the
eliminationoftheantibioticandaugmentserumantibiotic
concentrations, thereby increasing the potential
toxicity. Dogs with subclinical renal dysfunction are
more sensitive to the toxicity of gentamicin and
developoliguriaandacuterenalfailurethatmaynotbe
reversible from a high gentamicin dose [24].The local
renin-angiotensin system is activated leading to local
vasoconstriction causing a decrease in the glomerular
filtration rate [26]. The increase in plasma creatinine
(sCr) level due to reductions in glomerular filtration
rate is used as the suggestive measure of nephro-
toxicity. The detectable elevation in sCr and/or BUN
precedes mRNA expression products in urine and/or
kidney that could be used as potential biomarkers for
acute gentamicin related nephrotoxicity in dogs [27].
a. Sulfonamides:
b. Penicillin:
c. Cephalosporins:
d. Aminoglycosides:
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in vivo in vitro
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Nephrotoxicity is exacerbated by many other factors
that compromises renal blood flow. Co-administration
of certain drugs including furesomide, ethacrynic acid,
cyclosporin, cisplatin, and vancomycin (but not teico-
planin) have been reported to increase the risk of
nephrotoxicity[25].
Some aminoglycosides are more likely to cause
auditory toxicity (cochlear otoxicity) and others are
morelikelytocausevestibularototoxicity.Thismaybe
due to the distribution characteristics of each drug and
its ability to concentrate in each sensory organ and
result from damage to the sensory hair cells in the
cochlea and the labyrinth [28]. Unlike nephrotoxicity,
auditory or vestibular toxicity is often irreversible. A
rareformofauditorytoxicityaftersingledoseadminis-
tration of aminoglycosides has been described to be
associatedwithtwodifferentmutationsinthemitocho-
ndrial12SribosomalRNAgene[29].
Neuromuscularparalysisisveryrareascompared
to the nephrotoxic and ototoxic effects of amino-
glycosides. The neuromuscular blocking effects of
dihydrostreptomycin, gentamicin, neomycin, and
streptomycinhavebeendemonstratedwiththedoserate
of14-43mg/kg.Thepostsynapticblockingcomponent
of this effect can be reversed by a cholinesterase
inhibitor,suchasneostigmine,andtheapparentpresynapic
effect can be antagonized by the administration of
calcium[25].
Besides, tetracycline causesA-Colitis-X in horses,
drug fever in cats, and photosensitivity in grazing
animals.
Fluoroquinolones are an
important group of antibacterial agents widely used
veterinary practice in the treatment of infectious
diseases [25]. It mostly causes arthropathy in young
animals, retinal degeneration in cats, neuromuscular
paralysis in horses. Young and growing pups are most
prone to quinolones induced arthropathy especially on
weight-bearing joints, the underlying mechanism of
whichstillremainsobscured[25,31].Quinoloneshave
an inhibitory effect on DNA, collagen and proteo-
glycan synthesis and on the generation of oxygen
derived reactive molecules [32, 33]. Irreversible chon-
drotoxicity and tendinitis associated with quinolines
may also be explained on account of their chelating
propertiesforbi-andtri-valentionsmostlymagnesium
ions, leading to formation of free radicals or due to an
altered functionality of integrin receptors on chondro-
cyte and tenocytes surface [34].Tendons cannot easily
compensate these altered functions because of their
poor vascularization. Apoptosis of the tendon and
chondron cells, a consequence of altered -1 integrin
receptors and Map-kinase pathway is the final event in
the pathogenesis of fluoroquinolone-induced tendino-
pathiesasevidencedbyculturedhumantendoncellline
[32, 34]. The findings that quinolone-induced damage on
connectivetissueispartiallyduetomagnesiumchelation
also support the observation that patients with a latent
magnesium deficiency could be at an increased risk of
tendondisorders[34].
A recent study has proposed a possible bilateral
fluoroquinolone-associated uveitis, particularly the
incidenceofiristransilluminationandpigmentdispersion
amonghumanpatients[35].
Chloramphenicol,apowerfulbroad
spectrum bacteriostatic drug, is most often adminis-
tered in dogs with pneumonia, infection of the brain,
eye, and in anaerobic infection. Toxic adverse effects
of chloramphenicol include bone marrow depression,
gastrointestinal upsets, hypersensitivity reactions and
gray baby's syndrome [25, 26]. All dogs do not
experience side effects while taking chloramphenicol
but puppies unable to digest and process chloram-
phenicol the same way an adult canine can thus
resultingintoxicaccumulationofthechloramphenicol
in the puppy's body [26]. Chloramphenicol crosses the
blood brain barrier and reaches onto the foetus, and is,
therefore, contraindicated in pregnant bitch. Chloram-
phenicol is rarely associated with blood dyscrasias
wherethedrugtargetsthebonemarrow[25].
Gray baby's syndrome in neonates and infants
occurs due accumulation of unconjugated clroram-
phenicol in the body that blocks electron transport
system in liver, myocardium and skeletal muscle, and
is characterized by vomiting, hypothermia, ashen gray
cyanosis, cardiovascular collapse and sometimes
leading to death. The human and animal neonates are
deficient in microsomal enzymes and inadequately
metabolizethedrug[26].
Several diagnostic tests and therapy are being
practised to ameliorate drug hypersensitivity and
ADRs. Laboratory tests including skin testing radio-
allergosorbenttest(RAST)areconductedtostudyIgE-
mediated immune reaction with therapeutic interventions
of antihistamines, systemic corticosteroids and bron-
chodilators.Similarly,directorindirectCoombs'testis
carried out to read the cytotoxic immune reaction. Patch
test or lymphocyte proliferation assay is performed to
learn the delayed and cell-mediated immune reaction
and the present drug therapy is stopped with adminis-
tration of antihistamines and topical or systemic
corticosteroids.
Mostmacrolideantibioticsdo
not produce serious toxic effects in animals but tylosin
and tilmicosin have tendency to produce cardio-
vascular toxicity [26]. Very high doses and prolonged
useinhumanandanimalscauseuntowardeffectsnamely,
transientauditoryimpairmentandsuperinfection.Oral
erythromycin may be highly irritating to the stomach
andwhengivenbyinjectionmaycauseseverephlebitis.
The combination of some macrolides and statins used
forloweringcholesterolisnotadvisableandcanleadto
debilitating myopathy [36]. This is because some
macrolides (clarithromycin and erythromycin, not
azithromycin) are potent inhibitors of the cytochrome
P system,particularlyofCYP A .
Lincosamides are
e. Fluoroquinolones:
f. Chloramphenicol:
g. Macrolide antibiotics:
h. Lincosamide antibiotics:
β
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preferred bacteriostatic antibiotics in dermatological
problems in veterinary practice. They are well
absorbed orally and penetrate well into infected skin
and affects the bacteria including staphylococci [25,
26]. Rapid development of bacterial resistance and
occasional gastroenteric upset are the main disadvan-
tagesfortheiruse[37].Decreasedmilkproductionand
ketosisarealsocommonduetotoxicityoflincosamide
antibiotics in milch cows [38]. It also causes loose
stools in dogs and pigs, vomition in cats, and Pseudo-
membranous colitis in human, horses and other
herbivores respectively. However in some animals,
adverse effects have been noticed with parenterally
administeredlincomycin.
AnearlydetectionofthecauseofADRandprompt
treatment of anaphylaxis are essentially required for
successfulmanagement.Acutetherapyinemergencyis
directed toward oxygenation and maintenance of
normotension. The most appropriate therapy includes
the use of epinephrine, oxygen, vasopressors, cortico-
steroidsandadequatefluidreplacement.ADRneedsto
be differentiated from other symptoms to avoid the
discontinuanceofthenecessarydrugs.Acompleteand
thorough knowledge of drugs causing immunologic
reactions,patients'historyofallergyifanyandmastery
overuseofsatisfactoryalternativesagainsthypersensi-
tivity is a must. Adverse reaction can be minimized
throughuseofestablishedprotocolsforpremedication
or through desensitization achieved with graduated
dosageschedules.
A number of sulphonamides and
their combinations are being used to treat respiratory,
urinary tract, skin, or gastrointestinal infections in
veterinary practice. However, it is contraindicated in
pregnantornursinganimals,dehydratedanimalsandin
those animals suffering from bladder or kidney stones,
liver or kidney diseases.The pet should be encouraged
todrinkplentyofwatertopreventcrystalluriaformation
in the kidneys. Similarly, adequate drinking water
should be provided to dogs with routine monitoring of
blood cell abnormalities during sulphonamide admi-
nistration.
Penicillin for dogs is prescribed for
infections of the urinary tract, lungs, and kidneys.
Resistance to it mostly encountered when the drug
administration is stopped before the prescribed course
iscompleted,thuspromptingachancefortheinfection
toreturn.Atopicalpenicillinlotionorointmentmaybe
prescribed for various skin infections in dogs and also
sometimes used in treating leptospirosis, wounds, and
dental infections. In dogs and cats, penicillin-V is
administered @5.5-11mg/kg b wt at every 6-8 hour
interval. [25, 39].It is not used in animals hypersen-
sitive (allergic) to penicillins or -lactam antibiotics
such as cephalosporins. Penicillins can cross the
placenta,andhence,isnotadvisedinpregnantanimals
although no detrimental results to fetuses have been
reported.
Cephalosporinsarebroadspectrum
bactericidalantibioticsusedtotreatbacterialinfections
of the skin, urinary tract, respiratory tract, bones and
joints [25, 26, 39]. Cefadroxil is the most commonly
prescribed and FDAapproved medication used to treat
dogs and cats. However the drug is used with much
caution in pregnant and nursing animals as well as in
combinationwithprobenecidoraminoglycosideswhich
may aggravate neuromuscular blockade or nephro-
toxicity[25,40].
Aminoglycosides are not used in
animals hypersensitive (allergic) to aminoglycosides
and are also not prescribed in anaerobic bacterial
infection.Aminoglycosides is contraindicated in dogs
used for hearing sensation very frequently to perform
theirworkasthevestibularimpairmentisoftenirrever-
sible. Gentamicin therapy is also contraindicated in
nephrotoxicity,neuromusculardisordersandinpregnancy
ornursinganimals[32,37,38].
Renal damage in older dogs and heartworm
microfilaria infection, hypovolemic dehydration are
oftenthepredisposingfactorsforaminoglycosidetoxicity
[40]. It is highly advised to monitor the renal function
duringthecourseoftreatmentmostlythroughurinalysis
indicate early nephrotoxicity. The nephrotoxicity of
aminoglycoside is checked by adjusting the drug
dosing rate and duration of therapy, which under no
circumstance should be more than the recommended
dose in plasma [40, 41]. It is always commended to
avoid concurrent or sequential use of nephrotoxic,
ototoxic, or neuromuscular blocking drugs, particularly
other aminoglycosides because of their additive
effects. Concurrent administration of furosemide with
aminoglycosides may enhance nephrotoxicity [25, 26,
39].
Diuretics should not be employed together with
aminoglycosides as it increases the risk of kidney
damage.Productscausinghearingloss,vestibulardisease,
or kidney disease should not be recommended along
withaminoglycosidetherapyinordertoshyofffurther
complications [40, 41]. The possibility of neuromus-
cularblockadeandrespiratoryparalysisexistsifamino-
glycosides are given to patients receiving anaesthetics,
neuromuscular blockers, or massive transfusions of
citrate-anticoagulated blood. Calcium salts may reverse
neuromuscularblockadeifitoccurs.
ADR or drug toxicity is a common problem that
threatensthesafetyandhealthstatusofthepatients,but
asthewholerepresentsburdenonthewholehealthcare
system.Itisoftenpoorlydiagnosedanddocumentedin
day to day medical practice. The situation is even
grimmerinveterinaryfieldconditionsparticularlywhen
prescribedbyquacks,frequentpracticeofpolypharmacy
orfixeddosecombinations.ThediagnosisofADRand
mechanismsinvolvedarealsooftenhardlystudiedand
Prophylaxis and management of ADR
Conclusion
a. Sulphonamide:
b. Penicillin:
c. Cephalosporins:
d. Aminoglycosides:
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understood by the unskilled practitioners, and they
attributethesesymptomstotheprogressofthedisease.
Such scenario is more frequently India, particularly in
the companion animal practices, where over the
counter prescription is common and door step services
arebeingprovidedbypersonnelwithouthavingavalid
registrationIDfromVeterinaryCouncilofIndiaorState
VeterinaryCouncil.
Non-reportingofADRencounteredbytheclinician
is the biggest disadvantage to curb this situation. The
healthpractionersarerequiredtodevotemoreattention
to ADR and to identify risk factors in suspected idio-
syncraticADRs[42].
The first step in managing ADR or toxicity is to
discontinuethecausativemedicationanditssubstitution
with alternative medications having unrelated chemical
structures. The clinical consequences of cessation of
medication or substitution need to be closely monitored
by a competent professional. In majority of patients,
symptomsusuallyresolvewithintwoweeks.Systemic
corticosteroidsspeeduptherecoveryanduseoftopical
corticosteroids and oral antihistamines improve the
dermatologic symptoms. Elucidation of the key players
in mediation ofADRs will provide therapeutic targets
foritsmanagementandprevention.
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